The cooked meat carcinogen 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine activates the extracellular signal-regulated kinase mitogen-activated protein kinase pathway

Cancer Research

Volumn 67, Issue 23, 2007, Pages 11455-11462

  Creton, Stuart K ^a   Zhu, Huijun ^a   Gooderham, Nigel J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; ESTROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; BREAST CELL; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; COOKED FOOD; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MEAT; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; BREAST; CARCINOGENS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHEMOTAXIS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; IMIDAZOLES; IMMUNOBLOTTING; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROSTATIC NEOPLASMS; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 37049033647     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-2821     Document Type: Article

References (54)

1. WCRF. Food nutrition and the prevention of cancer: a global perspective. Washington (DC): American Institute for Cancer Research; 1997. p. 1-670.
2. Nagao M, Ushijima T, Wakabayashi K, et al. Dietary carcinogens and mammary carcinogenesis. Induction of rat mammary carcinomas by administration of heterocyclic amines in cooked foods. Cancer 1994;74:1063-9.
3. Sugimura T. Overview of carcinogenic heterocyclic amines. Mutat Res 1997;376:211-9.
4. Ito N, Hasegawa R, Sano M, et al. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis 1991;12:1503-6.
5. Shirai T, Sano M, Tamano S, et al. The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[ 4,5-b]pyridine (PhIP) derived from cooked foods. Cancer Res 1997;57:195-8.
6. Zhu J, Chang P, Bondy ML, et al. Detection of 2-amino-1-methyl-6- phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2003;12:830-7.
7. Ambrosone CB, Abrams SM, Gorlewska-Roberts K, Kadlubar FF. Hair dye use, meat intake, and tobacco exposure and presence of carcinogen-DNA adducts in exfoliated breast ductal epithelial cells. Arch Biochem Biophys 2007;464:169-75.
8. Malfatti MA, Dingley KH, Nowell-Kadlubar S, et al. The urinary metabolite profile of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine is predictive of colon DNA adducts after a low-dose exposure in humans. Cancer Res 2006;66:10541-7.
9. Tang D, Liu JJ, Rundle A, et al. Grilled meat consumption and PhIP-DNA adducts in prostate carcinogenesis. Cancer Epidemiol Biomarkers Prev 2007;16:803-8.
10. Bogen KT, Keating GA, Chan JM, et al. Highly elevated PSA and dietary PhIP intake in a prospective clinic-based study among African Americans. Prostate Cancer Prostatic Dis 2007;10:261-9.
11. Cross AJ, Peters U, Kirsh VA, et al. A prospective study of meat and meat mutagens and prostate cancer risk. Cancer Res 2005;65:11779-84.
12. Sinha R, Gustafson DR, Kulldorff M, et al. 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine, a carcinogen in high-temperature-cooked meat, and breast cancer risk. J Natl Cancer Inst 2000;92:1352-4.
13. Sinha R, Peters U, Cross AJ, et al. Meat, meat cooking methods and preservation, and risk for colorectal adenoma. Cancer Res 2005;65:8034-41.
14. Zhao K, Murray S, Davies DS, Boobis AR, Gooderham NJ. Metabolism of the food derived mutagen and carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5- b)pyridine (PhIP) by human liver microsomes. Carcinogenesis 1994;15:1285-8.
15. Rindgen D, Turesky RJ, Vouros P. Determination of in vitro formed DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine using capillary liquid chromatography/electrospray ionization/tandem mass spectrometry. Chem Res Toxicol 1995;8:1005-13.
16. Snyderwine EG, Thorgeirsson UP, Venugopal M, Roberts-Thomson SJ. Mammary gland carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Sprague-Dawley rats on high- and low-fat diets. Nutr Cancer 1998;31:160-7.
17. Venugopal M, Callaway A, Snyderwine EG. 2-Amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP) retards mammary gland involution in lactating Sprague-Dawley rats. Carcinogenesis 1999;20:1309-14.
18. Venugopal M, Agarwal R, Callaway A, Schut HA, Snyderwine EG. Inhibition of cell death in human mammary epithelial cells by the cooked meat-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine. Biochem Biophys Res Commun 1999;266:203-7.
19. Lauber SN, Ali S, Gooderham NJ. The cooked food derived carcinogen 2-amino-1-methyl-6-phenylimidazo[ 4,5-b]pyridine is a potent oestrogen: a mechanistic basis for its tissue-specific carcinogenicity. Carcinogenesis 2004;25:2509-17.
20. Stone R. Environmental estrogens stir debate. Science 1994;265:308-10.
21. English MA, Stewart PM, Hewison M. Estrogen metabolism and malignancy: analysis of the expression and function of 17β-hydroxysteroid dehydrogenases in colonic cancer. Mol Cell Endocrinol 2001;171:53-60.
22. Noble RL. The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res 1977;37:1929-33.
23. Maemura M, Iino Y, Koibuchi Y, Yokoe T, Morishita Y. Mitogen-activated protein kinase cascade in breast cancer. Oncology 1999;57:37-44.
24. Gioeli D, Mandell JW, Petroni GR, Frierson HF, Jr., Weber MJ. Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res 1999;59:279-84.
25. Scott KA, Turesky RJ, Wainman BC, Josephy PD. Hplc/ electrospray ionization mass spectrometric analysis of the heterocyclic aromatic amine carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in human milk. Chem Res Toxicol 2007;20:88-94.
26. Crews CM, Alessandrini A, Erikson RL. Erks: their fifteen minutes has arrived. Cell Growth Differ 1992;3:135-42.
27. Knize MG, Dolbeare FA, Cunningham PL, Felton JS. Mutagenic activity and heterocyclic amine content of the human diet. Princess Takamatsu Symp 1995;23:30-8.
28. Lynch AM, Knize MG, Boobis AR, Gooderham NJ, Davies DS, Murray S. Intra- and interindividual variability in systemic exposure in humans to 2-amino-3,8-dimethylimidazo[ 4,5-f]quinoxaline and 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine, carcinogens present in cooked beef. Cancer Res 1992;52:6216-23.
29. Tannheimer SL, Ethier SP, Caldwell KK, Burchiel SW. Benzo[a] pyrene- and TCDD-induced alterations in tyrosine phosphorylation and insulin-like growth factor signaling pathways in the MCF-10A human mammary epithelial cell line. Carcinogenesis 1998;19:1291-7.
30. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
31. Anand-Apte B, Zetter B. Signaling mechanisms in growth factor-stimulated cell motility. Stem Cells 1997;15:259-67.
32. Soule HD, Maloney TM, Wolman SR, et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 1990;50:6075-86.
33. Kiosses WB, Hahn KM, Giannelli G, Quaranta V. Characterization of morphological and cytoskeletal changes in MCF10A breast epithelial cells plated on laminin-5: comparison with breast cancer cell line MCF7. Cell Commun Adhes 2001;8:29-44.
34. Garrington TP, Johnson GL. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol 1999;11:211-8.
35. Viala E, Pouyssegur J. Regulation of tumor cell motility by ERK mitogen-activated protein kinases. Ann N Y Acad Sci 2004;1030:208-18.
36. Suzukawa K, Weber TJ, Colburn NH. AP-1, NF-κB, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model. Environ Health Perspect 2002;110:865-70.
37. Coutts AS, Murphy LC. Elevated mitogen-activated protein kinase activity in estrogen-nonresponsive human breast cancer cells. Cancer Res 1988;58:4071-4.
38. Houston SJ, Plunkett TA, Barnes DM, et al. Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer. Br J Cancer 1999;79:1220-6.
39. Nabha SM, Glaros S, Hong M, et al. Up-regulation of PKC-δ contributes to antiestrogen resistance in mammary tumor cells. Oncogene 2005;24:3166-76.
40. Nicholson RI, McClelland RA, Finlay P, et al. Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity. Eur J Cancer 1993;29A:1018-23.
41. Rocha RL, Hilsenbeck SG, Jackson JG, et al. Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival. Clin Cancer Res 1997;3:103-9.
42. Price DT, Della RG, Guo C, et al. Activation of extracellular signal-regulated kinase in human prostate cancer. J Urol 1999;162:1537-42.
43. Navolanic PM, Steelman LS, McCubrey JA. EGFR family signaling and its association with breast cancer development and resistance to chemotherapy. Int J Oncol 2003;22:237-52.
44. Pessin JE, Saltiel AR. Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 2000;106:165-9.
45. Koul HK, Chaturvedi L, Haung MY, et al. Role of p44/ 42 mitogen activated protein kinase signal transduction in PC-3 cells, a line of hormone independent prostate cancer cells. Proc Am Assoc Cancer Res 2003;44:852.
46. Cano E, Mahadevan LC. Parallel signal processing among mammalian MAPKs. Trends Biochem Sci 1995;20:117-22.
47. Yanagihara N, Toyohira Y, Ueno S, et al. Stimulation of catecholamine synthesis by environmental estrogenic pollutants. Endocrinology 2005;146:265-72.
48. Maggiolini M, Vivacqua A, Fasanella G, et al. The G protein-coupled receptor GPR30 mediates c-fos upregulation by 17β-estradiol and phytoestrogens in breast cancer cells. J Biol Chem 2004;279:27008-16.
49. Snyderwine EG, Davis CD, Schut HA, Roberts-Thomson SJ. Proliferation, development and DNA adduct levels in the mammary gland of rats given 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and a high fat diet. Carcinogenesis 1998;19:1209-15.
50. Takayama K, Yamashita K, Wakabayashi K, Sugimura T, Nagao M. DNA modification by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rats. Jpn J Cancer Res 1989;80:1145-8.
51. Gooderham NJ, Creton S, Lauber SN, Zhu H. Mechanisms of action of the carcinogenic heterocyclic amine PhIP. Toxicol Lett 2007;168:269-77.
52. Bennion BJ, Cosman M, Lightstone FC, et al. PhIP carcinogenicity in breast cancer: computational and experimental evidence for competitive interactions with human estrogen receptor. Chem Res Toxicol 2005;18:1528-36.
53. Nakai Y, Nelson WG, De Marzo AM. The dietary charred meat carcinogen 2-amino-1-methyl-6-phenylimidazo[ 4,5-b]pyridine acts as both a tumor initiator and promoter in the rat ventral prostate. Cancer Res 2007;67:1378-84.
54. Crofts FG, Sutter TR, Strickland PT. Metabolism of 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine by human cytochrome P4501A1, P4501A2 and P4501B1. Carcinogenesis 1998;19:1969-73.